Cinven, a global private equity firm headquartered in London, has sold a 15% stake in Synlab, a medical diagnostics provider based in Munich, to US strategic investor Labcorp for €140 million (US$156 million). With this acquisition, Labcorp will join the board of Synlab alongside Cinven and other co-investors.



